| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | 0.0023 | 1 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | 0.00087 | 1 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00074 | 1 |
| mRNA | XMD11-85h | GDSC1000 | pan-cancer | AAC | -0.00091 | 1 |